IT1255470B - Compounds active as inhibitors of HMG-CoA reductase enzyme - Google Patents
Compounds active as inhibitors of HMG-CoA reductase enzymeInfo
- Publication number
- IT1255470B IT1255470B ITMI921854A ITMI921854A IT1255470B IT 1255470 B IT1255470 B IT 1255470B IT MI921854 A ITMI921854 A IT MI921854A IT MI921854 A ITMI921854 A IT MI921854A IT 1255470 B IT1255470 B IT 1255470B
- Authority
- IT
- Italy
- Prior art keywords
- hmg
- inhibitors
- coa reductase
- reductase enzyme
- compounds active
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- 102000004286 Hydroxymethylglutaryl CoA Reductases Human genes 0.000 title 1
- 108090000895 Hydroxymethylglutaryl CoA Reductases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 201000001320 Atherosclerosis Diseases 0.000 abstract 1
- 208000031226 Hyperlipidaemia Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Abstract
Compounds of general formula I <IMAGE> in which the radicals have the meaning specified in the description, which are useful as drugs in the treatment of antihypercholesterolaemia, in the treatment of atherosclerosis and hyperlipidaemia are described.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI921854A IT1255470B (en) | 1992-07-30 | 1992-07-30 | Compounds active as inhibitors of HMG-CoA reductase enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI921854A IT1255470B (en) | 1992-07-30 | 1992-07-30 | Compounds active as inhibitors of HMG-CoA reductase enzyme |
Publications (3)
Publication Number | Publication Date |
---|---|
ITMI921854A0 ITMI921854A0 (en) | 1992-07-30 |
ITMI921854A1 ITMI921854A1 (en) | 1994-01-30 |
IT1255470B true IT1255470B (en) | 1995-11-02 |
Family
ID=11363776
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ITMI921854A IT1255470B (en) | 1992-07-30 | 1992-07-30 | Compounds active as inhibitors of HMG-CoA reductase enzyme |
Country Status (1)
Country | Link |
---|---|
IT (1) | IT1255470B (en) |
-
1992
- 1992-07-30 IT ITMI921854A patent/IT1255470B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ITMI921854A1 (en) | 1994-01-30 |
ITMI921854A0 (en) | 1992-07-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HU0004863D0 (en) | ||
PL346660A1 (en) | Method for treating atherosclerosis employing an ap2 inhibitor and combination | |
AU6613896A (en) | Chemical compounds | |
EP0433842A3 (en) | 1,2,3-triazole derivatives active as inhibitors of the enzyme hmg-coa reductase and pharmaceutical compositions containing them | |
EP0352864A3 (en) | Compounds active as inhibitors of the cholesterol biosynthesis | |
MY136037A (en) | Biphenyl pyrimidone lp-pla2 inhibitors | |
WO1996009827A3 (en) | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor | |
DK0649425T3 (en) | Pyridino-, pyrrolidino- and azepino-substituted oxymers useful as anti-atherosclerosis and anti-hypercholester esters | |
AU5820294A (en) | Endothelin converting enzyme inhibitors | |
MXPA04004372A (en) | Heterocyclic derivatives of glycinamide and their medical use. | |
ES2090177T3 (en) | DERIVATIVES OF PIRROL. | |
NO996206L (en) | Farnesyltransferase inhibitors in combination with HMG COA reductase inhibitors for the treatment of cancer | |
BG105003A (en) | Combinations of protein farnesyltransfer and hmg coa reductase inhibitors and their use to treat cancer | |
AU6212398A (en) | 2-amino-substituted pyridines which can be used for the treatment of arteriosclerosis and hyperclipoproteinaemia | |
IT1255470B (en) | Compounds active as inhibitors of HMG-CoA reductase enzyme | |
AU7529200A (en) | Composition useful for conditioning sludge derived from the treatment of an aqueous medium and uses thereof | |
WO1996026728A3 (en) | Use of moxonidine for the treatment of atherosclerosis | |
NZ501368A (en) | 3Beta-27-dihydroxy-5-cholesten-7-one and its use in pharmaceutical compositions | |
EP0930360A3 (en) | Microbiological diagnostical device |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
0001 | Granted | ||
TA | Fee payment date (situation as of event date), data collected since 19931001 |
Effective date: 19970612 |